Date  |
|
| Mar 30, 2020 |
CEL-SCI Announces Change of Location to 2020 Annual Meeting of Shareholders |
| Mar 26, 2020 |
CEL-SCI Announces the Closing of Its $7.7 Million Bought Deal |
| Mar 24, 2020 |
CEL-SCI Increases Previously Announced Bought Deal to $7.7 Million |
| Mar 23, 2020 |
CEL-SCI Announces Bought Deal Offering |
| Mar 23, 2020 |
CEL-SCI to Develop LEAPS COVID-19 Immunotherapy in Collaboration with University of Georgia Center for Vaccines and Immunology |
| Mar 9, 2020 |
CEL-SCI Initiates Development of Immunotherapy to Treat COVID-19 Coronavirus Infection |
| Feb 26, 2020 |
CEL-SCI Corporation Issues Letter to Shareholders |
| Feb 10, 2020 |
CEL-SCI Corporation Reports First Quarter Fiscal 2020 Financial Results |
| Feb 6, 2020 |
CEL-SCI to Present at 2020 BIO CEO & Investor Conference |
| Jan 10, 2020 |
CEL-SCI to Participate in Upcoming Investor Conferences |